News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
878,784 Results
Type
Article (88518)
Company Profile (814)
Press Release (789419)
Multimedia
Podcasts (225)
Webinars (34)
Section
Business (233476)
Career Advice (4156)
Deals (39940)
Drug Delivery (172)
Drug Development (91593)
Employer Resources (207)
FDA (18501)
Job Trends (17465)
News (398453)
Policy (40011)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3043)
Academic (2)
Accelerated approval (48)
Adcomms (38)
Allergies (181)
Alliances (56986)
ALS (215)
Alzheimer's disease (1909)
Antibody-drug conjugate (ADC) (480)
Approvals (18773)
Artificial intelligence (783)
Autoimmune disease (282)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (235)
Biotechnology (486)
Bladder cancer (194)
Brain cancer (78)
Breast cancer (762)
Cancer (6009)
Cardiovascular disease (517)
Career advice (3587)
Career pathing (48)
CAR-T (348)
CDC (73)
Celiac Disease (2)
Cell therapy (966)
Cervical cancer (47)
Clinical research (78217)
Collaboration (2212)
Company closure (7)
Compensation (1374)
Complete response letters (100)
COVID-19 (3023)
CRISPR (115)
C-suite (1143)
Cystic fibrosis (162)
Data (7732)
Decentralized trials (3)
Denatured (84)
Depression (183)
Dermatology (74)
Diabetes (618)
Diagnostics (7475)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (386)
Drug pricing (242)
Drug shortages (39)
Duchenne muscular dystrophy (293)
Earnings (101606)
Editorial (75)
Employer branding (25)
Employer resources (174)
Events (137141)
Executive appointments (1139)
FDA (22273)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (35)
Funding (1809)
Gene editing (253)
Generative AI (85)
Gene therapy (789)
GLP-1 (1231)
Government (5531)
Grass and pollen (8)
Guidances (408)
Healthcare (21066)
HIV (86)
Huntington's disease (59)
IgA nephropathy (98)
Immunology and inflammation (337)
Immuno-oncology (98)
Indications (174)
Infectious disease (3392)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (292)
Interviews (818)
IPO (17982)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (21)
Labor market (109)
Layoffs (673)
Leadership (48)
Legal (10171)
Liver cancer (107)
Longevity (33)
Lung cancer (800)
Lymphoma (431)
Machine learning (62)
Management (66)
Manufacturing (1092)
MASH (197)
Medical device (15196)
Medtech (15291)
Mergers & acquisitions (23183)
Metabolic disorders (1649)
mRNA (236)
Multiple sclerosis (191)
NASH (24)
Neurodegenerative disease (451)
Neuropsychiatric disorders (121)
Neuroscience (3513)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (76)
Obesity (801)
Opinion (364)
Ovarian cancer (214)
Pain (266)
Pancreatic cancer (300)
Parkinson's disease (381)
Partnered (39)
Patents (608)
Patient recruitment (666)
Peanut (66)
People (67616)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24167)
Phase 2 (33968)
Phase 3 (25554)
Pipeline (8063)
Policy (380)
Postmarket research (3557)
Preclinical (10881)
Press Release (72)
Prostate cancer (303)
Psychedelics (66)
Radiopharmaceuticals (349)
Rare diseases (1156)
Real estate (7454)
Recruiting (81)
Regulatory (29944)
Reports (76)
Research institute (2761)
Resumes & cover letters (653)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (187)
Series A (304)
Series B (221)
Service/supplier (30)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (188)
Sponsored (54)
Startups (4358)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (138)
Vaccines (1253)
Venture capital (118)
Weight loss (554)
Women's health (127)
Worklife (24)
Date
Today (197)
Last 7 days (702)
Last 30 days (3042)
Last 365 days (33114)
2026 (11133)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1295)
Alabama (100)
Alaska (7)
Arizona (382)
Arkansas (16)
Asia (52015)
Australia (9143)
California (13294)
Canada (3764)
China (1409)
Colorado (574)
Connecticut (587)
Delaware (408)
Europe (119814)
Florida (1972)
Georgia (434)
Hawaii (4)
Idaho (69)
Illinois (1144)
India (97)
Indiana (622)
Iowa (25)
Japan (534)
Kansas (138)
Kentucky (54)
Louisiana (45)
Maine (87)
Maryland (1628)
Massachusetts (9704)
Michigan (402)
Minnesota (745)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (145)
New Hampshire (92)
New Jersey (3559)
New Mexico (33)
New York (3511)
North Carolina (1805)
North Dakota (10)
Northern California (6526)
Ohio (411)
Oklahoma (26)
Oregon (55)
Pennsylvania (2649)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5189)
Tennessee (212)
Texas (2143)
United States (47746)
Utah (398)
Vermont (1)
Virginia (340)
Washington D.C. (88)
Washington State (1102)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
There are 878,784 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
April 29, 2026
·
9 min read
Press Releases
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
April 29, 2026
·
4 min read
Press Releases
Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias
April 29, 2026
·
3 min read
Press Releases
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
April 29, 2026
·
4 min read
Earnings
GSK’s Shingrix strategy shift drives sales beat even as vaccines slow
While sales for most of GSK’s shots slumped as vaccine skepticism continues to climb in the U.S., Shingrix jumped 20% to almost $1.4 billion in the first quarter, emerging as the pharma’s top-selling product.
April 29, 2026
·
2 min read
·
Tristan Manalac
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
The settlements delay the entry of generic copies of Pfizer’s Vyndamax by almost three years, stabilizing sales of a drug that generated $3.8 billion in the U.S. last year.
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® - Early-Stage Invasive Breast Cancer Assay
April 29, 2026
·
3 min read
Press Releases
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium at Johns Hopkins University
April 29, 2026
·
11 min read
Press Releases
Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)
April 29, 2026
·
3 min read
Press Releases
Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD
April 29, 2026
·
9 min read
1 of 87,879
Next
